Annual Current Liabilities
$58.10 M
+$29.03 M+99.88%
December 31, 2023
Summary
- As of February 7, 2025, SNDX annual total current liabilities is $58.10 million, with the most recent change of +$29.03 million (+99.88%) on December 31, 2023.
- During the last 3 years, SNDX annual current liabilities has risen by +$39.22 million (+207.84%).
- SNDX annual current liabilities is now at all-time high.
Performance
SNDX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$59.38 M
+$16.91 M+39.80%
September 30, 2024
Summary
- As of February 7, 2025, SNDX quarterly total current liabilities is $59.38 million, with the most recent change of +$16.91 million (+39.80%) on September 30, 2024.
- Over the past year, SNDX quarterly current liabilities has increased by +$20.20 million (+51.57%).
- SNDX quarterly current liabilities is now at all-time high.
Performance
SNDX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
SNDX Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +99.9% | +51.6% |
| 3 y3 years | +207.8% | +94.3% |
| 5 y5 years | +260.7% | +94.3% |
SNDX Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +180.9% | at high | +187.1% |
| 5 y | 5-year | at high | +216.3% | at high | +376.3% |
| alltime | all time | at high | +2028.1% | at high | +2749.2% |
Syndax Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $59.38 M(+39.8%) |
| Jun 2024 | - | $42.47 M(-16.4%) |
| Mar 2024 | - | $50.80 M(-12.5%) |
| Dec 2023 | $58.10 M(+99.9%) | $58.10 M(+48.3%) |
| Sep 2023 | - | $39.17 M(+29.9%) |
| Jun 2023 | - | $30.17 M(+27.2%) |
| Mar 2023 | - | $23.72 M(-18.4%) |
| Dec 2022 | $29.07 M(+40.5%) | $29.07 M(+39.7%) |
| Sep 2022 | - | $20.80 M(-32.7%) |
| Jun 2022 | - | $30.93 M(+1.2%) |
| Mar 2022 | - | $30.55 M(+47.7%) |
| Dec 2021 | $20.68 M(+9.6%) | $20.68 M(-28.0%) |
| Sep 2021 | - | $28.71 M(+18.2%) |
| Jun 2021 | - | $24.29 M(-1.1%) |
| Mar 2021 | - | $24.57 M(+30.2%) |
| Dec 2020 | $18.87 M(+2.7%) | $18.87 M(+24.5%) |
| Sep 2020 | - | $15.16 M(+21.6%) |
| Jun 2020 | - | $12.47 M(-33.7%) |
| Mar 2020 | - | $18.79 M(+2.3%) |
| Dec 2019 | $18.37 M | $18.37 M(+0.4%) |
| Sep 2019 | - | $18.29 M(+4.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $17.49 M(+11.7%) |
| Mar 2019 | - | $15.66 M(-2.8%) |
| Dec 2018 | $16.11 M(+1.9%) | $16.11 M(-5.4%) |
| Sep 2018 | - | $17.02 M(-11.8%) |
| Jun 2018 | - | $19.30 M(+14.1%) |
| Mar 2018 | - | $16.91 M(+7.0%) |
| Dec 2017 | $15.80 M(+52.4%) | $15.80 M(+11.2%) |
| Sep 2017 | - | $14.21 M(+23.5%) |
| Jun 2017 | - | $11.51 M(+4.7%) |
| Mar 2017 | - | $10.99 M(+6.0%) |
| Dec 2016 | $10.37 M(+113.9%) | $10.37 M(+13.3%) |
| Sep 2016 | - | $9.15 M(+39.6%) |
| Jun 2016 | - | $6.55 M(-6.9%) |
| Mar 2016 | - | $7.04 M(+45.1%) |
| Dec 2015 | $4.85 M(-53.2%) | $4.85 M(-64.0%) |
| Sep 2015 | - | $13.47 M(+30.2%) |
| Dec 2014 | $10.35 M(+279.0%) | $10.35 M(+7.1%) |
| Sep 2014 | - | $9.66 M(+109.0%) |
| Jun 2014 | - | $4.62 M(+121.8%) |
| Mar 2014 | - | $2.08 M(-23.7%) |
| Dec 2013 | $2.73 M(-89.1%) | $2.73 M |
| Dec 2012 | $25.10 M | - |
FAQ
- What is Syndax Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Syndax Pharmaceuticals?
- What is Syndax Pharmaceuticals annual current liabilities year-on-year change?
- What is Syndax Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Syndax Pharmaceuticals?
- What is Syndax Pharmaceuticals quarterly current liabilities year-on-year change?
What is Syndax Pharmaceuticals annual total current liabilities?
The current annual current liabilities of SNDX is $58.10 M
What is the all time high annual current liabilities for Syndax Pharmaceuticals?
Syndax Pharmaceuticals all-time high annual total current liabilities is $58.10 M
What is Syndax Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, SNDX annual total current liabilities has changed by +$29.03 M (+99.88%)
What is Syndax Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of SNDX is $59.38 M
What is the all time high quarterly current liabilities for Syndax Pharmaceuticals?
Syndax Pharmaceuticals all-time high quarterly total current liabilities is $59.38 M
What is Syndax Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, SNDX quarterly total current liabilities has changed by +$20.20 M (+51.57%)